($50,000 award, deadline March 1st, 2022).
National Call for Projects - US ($50,000 award, deadline October 15th, 2021).
“Gut microbiota and its impact beyond the digestive system” https://www.biocodexmicrobiotafoundation.com/national-call-projects/usa.
Biocodex Microbiota Foundation: ($235,000 award, deadline November 30th, 2021).
The National Science Foundation’s Directorate for Biological Sciences (BIO) is seeking a candidate for the position of Deputy Division Director in the Division of Molecular and Cellular Biosciences (MCB). We hope you can share this announcement with your faculty or colleagues that you think might be appropriate for the position.
What is RAPID?
A National Institute of Allergy and Infectious Diseases (NIAID) all-expense-paid faculty development program that aims to enhance faculty career success and success in obtaining NIH or equivalent funding. One-year commitment Virtual Summer Institute, July 12-23, 2021 2-day Mid-Year Meeting Second Summer Institute in 2022.
Who is RAPID for?
The Michigan Biomedical Venture Fund (MBVF) invests in biomedical startup companies with U-M licensed IP in the domain of therapeutics, devices, diagnostics, or health IT. The MBVF is a collaborative effort between the U-M College of Engineering’s Center for Entrepreneurship (CFE) and U-M Medical School’s Fast Forward Medical Innovation program (FFMI) program.
Deadline: May 28, 2021
Michigan Drug Discovery (MDD) and Sun Pharma Research Company (SPARC) are now accepting proposals for the SPARC-MDD Partnership Grants, which provide funding and collaborative support for drug discovery projects led by U-M faculty.
Agilent Early Career Professor Award 2018
Internal Deadline: Monday, November 6, 2017 (12:00 PM)
Sponsor Deadline: Wednesday, February 28, 2018
The University of Michigan Regional Comprehensive Metabolomics Resource Core (MRC)2 is pleased to announce the 2016 Pilot and Feasibility Grant Program (the full text of the RFA can be found here). This program is intended to provide opportunities for investigators to advance basic, clinical and translational biomedical science by incorporating metabolomic technologies into their research program.
Funding Opportunity Number: DE-FOA-0001458